Prevalence Evolution and Impact of Cardiovascular Risk Factors on Allograft and Renal Transplant Patient Survival

Transplantation Proceedings

Volumn 41, Issue 6, 2009, Pages 2151-2155

  Diaz J M ^a,c   Gich, I ^b,d   Bonfill, X ^b,d   Sola R ^a,d   Guirado, L ^a,c   Facundo, C ^a,c   Sainz, Z ^a   Puig, T ^b,e   Silva, I ^a   Ballarin J ^a,c  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Fundación Renal and Red de Investigación Renal REDinREN   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e Heart Failure Research Network (REDINSCOR)   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN ANTAGONIST; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; POLYCLONAL ANTIBODY; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; EXERCISE; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVORS; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE;

EID: 68949212925     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.134     Document Type: Article

References (33)

1. Ojo A.O. Cardiovascular complications after renal transplantation and their prevention. Transplantation 82 (2006) 603
2. Marcen R. Cardiovascular risk factors in renal transplantation-current controversies. Nephrol Dial Transplant 21 suppl 3 (2006) iii3
3. Ducloux D., Kazory A., and Chalopin J.M. Predicting coronary heart disease in renal transplant recipients: a prospective study. Kidney Int 66 (2004) 441
4. Opelz G., and Dohler B. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant 5 (2005) 2725
5. Courivaud C., Kazory A., Simula-Faivre D., et al. Metabolic syndrome and atherosclerotic events in renal transplant recipients. Transplantation 83 (2007) 1577
6. Meier-Kriesche H.U., Schold J.D., Srinivas T.R., et al. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 4 (2004) 378
7. Diaz J.M., Sainz Z., Guirado L.L., et al. Risk factors for cardiovascular disease after renal transplantation. Transplant Proc 35 (2003) 1722
8. Kasiske B.L., Anjum S., Shah R., et al. Hypertension after kidney transplantation. Am J Kidney Dis 43 (2004) 1071
9. Opelz G., Wujciak T., and Ritz E. Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int 53 (1998) 217
10. Martinez-Castelao A., Hernandez M.D., Pascual J., et al. Detection and treatment of post kidney transplant hyperglycemia: a Spanish multicenter cross-sectional study. Transplant Proc 37 (2005) 3813
11. Schiel R., Heinrich S., Steiner T., et al. Long-term prognosis of patients after kidney transplantation: a comparison of those with or without diabetes mellitus. Nephrol Dial Transplant 20 (2005) 611
12. de Mattos A.M., Prather J., Olyaei A.J., et al. Cardiovascular events following renal transplantation: role of traditional and transplant-specific risk factors. Kidney Int 70 (2000) 757
13. Cosio F.G., Pesavento T.E., Kim S., et al. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 62 (2002) 1440
14. Kasiske B.L., Snyder J.J., Gilbertson D., et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3 (2003) 178
15. Medrano M.J., Cerrato E., Boix R., et al. [Cardiovascular risk factors in Spanish population: metaanalysis of cross-sectional studies]. Med Clin (Barc) 124 (2005) 606
16. Tse K.C., Lam M.F., Yip P.S., et al. A long-term study on hyperlipidemia in stable renal transplant recipients. Clin Transplant 18 (2004) 274
17. Cosio F.G., Pesavento T.E., Pelletier R.P., et al. Patient survival after renal transplantation: III. The effects of statins. Am J Kidney Dis 40 (2002) 638
18. Yavuz A., Tuncer M., Gurkan A., et al. Cigarette smoking in renal transplant recipients. Transplant Proc 36 (2004) 108
19. Kasiske B.L., and Klinger D. Cigarette smoking in renal transplant recipients. J Am Soc Nephrol 11 (2000) 753
20. Ponticelli C., Villa M., Cesana B., et al. Risk factors for late kidney allograft failure. Kidney Int 62 (2002) 1848
21. Prommool S., Jhangri G.S., Cockfield S.M., et al. Time dependency of factors affecting renal allograft survival. J Am Soc Nephrol 11 (2000) 565
22. Mange K.C., Feldman H.I., Joffe M.M., et al. Blood pressure and the survival of renal allografts from living donors. J Am Soc Nephrol 15 (2004) 187
23. Winkelmayer W.C., Kewalramani R., Rutstein M., et al. Pharmacoepidemiology of anemia in kidney transplant recipients. J Am Soc Nephrol 15 (2004) 1347
24. Hariharan S., McBride M.A., Cherikh W.S., et al. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 62 (2002) 311
25. Tutone V.K., Mark P.B., Stewart G.A., et al. Hypertension, antihypertensive agents and outcomes following renal transplantation. Clin Transplant 19 (2005) 181
26. Aakhus S., Dahl K., and Wideroe T.E. Cardiovascular morbidity and risk factors in renal transplant patients. Nephrol Dial Transplant 14 (1999) 648
27. Wissing K.M., Abramowicz D., Broeders N., et al. Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection. Transplantation 70 (2000) 464
28. Roodnat J.I., Mulder P.G., Zietse R., et al. Cholesterol as an independent predictor of outcome after renal transplantation. Transplantation 69 (2000) 1704
29. Kasiske B.L., Chakkera H.A., and Roel J. Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 11 (2000) 1735
30. Booth J.C., Joseph J.T., and Jindal R.M. Influence of hypercholesterolemia on patient and graft survival in recipients of kidney transplants. Clin Transplant 17 (2003) 101
31. Aakhus S., Dahl K., and Wideroe T.E. Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up. Clin Transplant 18 (2004) 596
32. Jassal S.V., Schaubel D.E., and Fenton S.S. Baseline comorbidity in kidney transplant recipients: a comparison of comorbidity indices. Am J Kidney Dis 46 (2005) 136
33. Wu C., Evans I., Joseph R., et al. Comorbid conditions in kidney transplantation: association with graft and patient survival. J Am Soc Nephrol 16 (2005) 3437